Authors

• Emiko Ando (ORCID: https://orcid.org/0000-0002-8782-0946)
• Min Hee Hong (ORCID: https://orcid.org/0000-0003-3490-2195)
• Dévan Rajendran (ORCID: https://orcid.org/0000-0001-7337-3375)
• Soe Pwint Phoo Mon
• S. Cheng
• Mark Brooke (ORCID: https://orcid.org/0009-0004-9595-3548)
• Yasushi Goto
• Hyungshin Yim (ORCID: https://orcid.org/0000-0001-7945-3472)
• Regina Gowindah (ORCID: https://orcid.org/0000-0002-4486-8894)
• Chee Khoon Lee (ORCID: https://orcid.org/0000-0003-2955-9820)
• Jane Tsai
• Xue Yang (ORCID: https://orcid.org/0000-0003-2768-1865)
• Grace Kah Mun Low (ORCID: https://orcid.org/0000-0001-6938-4573)
• Naomi Kishiwada
• Kang Yun Lee
• Hisakazu Aoshima
• Yiting Liu (ORCID: https://orcid.org/0009-0006-0620-3847)

Institutions

• Oracle (United States) (US)
• Janssen (Belgium) (BE)
• Peking University (CN)
• Severance Hospital (KR)
• Pancreatic Cancer Action Network (US)
• National Cancer Center (US)
• Peking University Cancer Hospital (CN)
• Johnson & Johnson (Singapore) (SG)
• Lung Foundation Australia (AU)
• Formosa Plastics (Taiwan) (TW)
• Community Living (US)
• St George Hospital (AU)
• Shiseido Group (Japan) (JP)
• Korean Cancer Association (KR)
• Infineon Technologies (Singapore) (SG)
• Ministry of Education (ET)
• Adaptations Glassware Cooperative (US)
• St. George Hospital (IN)
• National University of Formosa (AR)
• Tokyo National Hospital (JP)
• Taipei Medical University-Shuang Ho Hospital (TW)
• The Patients Association (GB)
• Finisar (United States) (US)

Publication Details

Journal

Future Oncology

Published

2025-06-08

DOI

https://doi.org/10.1080/14796694.2025.2499511

Citations

1

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

1.52